Athlete's Foot (TERBINAFINE) (terbinafine HCl)
Topical Antifungals Topical Cream (GRAM)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Terbinafine hydrochloride is a synthetic allylamine antifungal agent.
Terbinafine hydrochloride is a synthetic allylamine antifungal agent. Terbinafine is derived from naphthalenemethanamine, and is structurally and pharmacologically related to naftifine.
Terbinafine is active in vitro against dermatophytes, including Epidermophyton floccosum, Trichophyton mentagrophytes, T. rubrum, T. verrucosum, Microsporum canis, and M. gypseum. The drug also is active in vitro against Malassezia furfur and some Candida, including C. albicans and C. parapsillosis. The antifungal spectrum of activity of terbinafine is similar to that of naftifine.
Terbinafine usually is fungicidal in action against susceptible dermatophytes, but may be fungicidal or fungistatic against Candida. Terbinafine is more active than azole antifungals (e.g., itraconazole, ketoconazole) against dermatophytes, but is less active than these drugs against Candida.
Following topical application of terbinafine hydrochloride 1% cream or 1% solution to healthy skin, percutaneous absorption occurs and terbinafine concentrations attained in the stratum corneum are similar with both preparations. Terbinafine is absorbed systemically following topical application to intact skin, and low concentrations of the drug are attained in plasma. Systemically absorbed terbinafine is extensively metabolized.
Approximately 75% of percutaneously absorbed terbinafine is eliminated in urine, principally as metabolites. Following topical application to skin, the half-life of systemically absorbed terbinafine is approximately 21 hours.
USES: This medication is used to treat a variety of fungal skin infections such as ringworm, athlete's foot, and jock itch. This medication is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs. Terbinafine is an antifungal that works by preventing the growth of fungus.
Generic name: terbinafine HCl
Pronunciation: (ter-BIN-uh-feen)
Drug class: Topical Antifungals
Therapeutic class: Dermatological
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Athlete's Foot (TERBINAFINE)
Indications
The following indications are listed for Athlete's Foot (TERBINAFINE):
- Tinea Corporis
- Tinea Cruris
- Tinea Pedis
Also known as: Corporeal Ringworm, Dermatomycosis Pedis, Dhobie Itch, Eczema Marginatum, Jock Itch, Tinea Circinata, Tinea Glabrosa, Tinea Inguinalis, Tinea Of The Foot.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
| Drug label | Dosing type | Instructions |
|---|---|---|
| Athlete's Foot 1% Cream | Maintenance | Apply to the affected and surrounding areas of skin by topical route once daily. |
| Drug label | Dosing type | Instructions |
|---|---|---|
| Terbinafine 1% Cream | Maintenance | Apply to the affected and surrounding areas of skin by topical route once daily. |
| Eq Terbinafine 1% Cream | Maintenance | Apply to the affected and surrounding areas of skin by topical route once daily. |
| Gnp Terbinafine 1% Cream | Maintenance | Apply to the affected and surrounding areas of skin by topical route once daily. |
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
Topical preparations containing terbinafine are contraindicated in patients hypersensitive to the drug or any ingredient in the formulation.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
- No disease contraindications
Adverse reactions
The most frequent adverse effects reported with topical terbinafine are irritation, burning/tingling, pruritus, dryness, skin exfoliation, and erythematous rash.
Rare or Very Rare
- Blistering skin
- Erythema
- Paresthesia
- Pruritus of skin
- Skin inflammation
- Skin irritation
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
Topical terbinafine should not be used for self-medication in children younger than 12 years of age unless directed by a clinician; safety and efficacy have not been established in children in this age group.
Category B.
Terbinafine is distributed into milk following oral administration. A decision should be made to discontinue nursing or the drug.
No enhanced messaging available.
ICD codes
| Code | Type | Description |
|---|---|---|
| Tinea corporis | ||
| B35.4 | ICD10CM | Tinea corporis |
| Tinea cruris | ||
| B35.6 | ICD10CM | Tinea cruris |
| Tinea pedis | ||
| B35.3 | ICD10CM | Tinea pedis |
ICD code information from First Databank (FDB).
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.